✦ LIBER ✦

Drug safety assessment in clinical trials: methodological challenges and opportunities

✍ Scribed by Sonal Singh, Yoon K Loke

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Surrogate markers in clinical trials—Cha

✍ Raphaël Duivenvoorden; Eric de Groot; Erik S.G. Stroes; John J.P. Kastelein 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 679 KB

The opportunities and challenges in cond

✍ Bansal, Navneeta 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 598 KB

Pediatric Stroke: Opportunities and Chal

✍ Steven G. Pavlakis; Deborah G. Hirtz; Gabrielle deVeber 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Safety biomarkers: Opportunities and cha

✍ Ina Schuppe-Koistinen 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Methodological Issues in Clinical Trials

✍ Kenneth A. Holroyd; Scott W. Powers; Frank Andrasik 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Cardiovascular Function in Nonclinical D

✍ Sarazan, R. D.; Mittelstadt, S.; Guth, B.; Koerner, J.; Zhang, J.; Pettit, S. 📂 Article 📅 2011 🏛 SAGE Publications 🌐 English ⚖ 367 KB